Irbesartan: all 71 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA NephropathyNot yet recruitingNCT07360002Not applicable
- The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.RecruitingNCT06208072Not applicable
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for SchizophreniaTerminatedNCT00794963Not applicableResults posted
- Nephropathy In Type 2 Diabetes and Cardio-renal EventsCompletedNCT00535925Phase 4Results posted
- Irbesartan and Atenolol in Hypertensive Heart DiseaseCompletedNCT00389168Phase 2/3Results posted
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)CompletedNCT00249795Phase 3Results posted
- Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)CompletedNCT00095238Phase 3Results posted
- Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy VolunteersCompletedNCT05688098Phase 1
- Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy VolunteersCompletedNCT05663073Phase 1
- Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension PatientsCompletedNCT05475665Phase 3
- A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese SubjectsStatus unknownNCT05297929Phase 1
- Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential HypetensionCompletedNCT04488978Phase 2
- A Study to Evaluate ALN-AGT01 in Patients With HypertensionCompletedNCT03934307Phase 1
- Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and IrbesartanCompletedNCT03147677Phase 4
- Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and HypertensionCompletedNCT02842359Phase 4
- Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)CompletedNCT02597361Phase 3
- Effectiveness of Avapro in Obese Normotensive/Hypertensive African AmericansStatus unknownNCT02386293Phase 2
- Multiple Treatments for Ebola Virus Disease (EVD)Status unknownNCT02380625Phase 1/2
- Angiotensin II Antagonist in Severe SepsisStatus unknownNCT01992796Phase 3
- Drug Interaction Between Irbesartan and HydrochlorothiazideCompletedNCT01858610Not applicable
- Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male SubjectsCompletedNCT01825850Phase 1
- Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted ConditionsCompletedNCT01712139Not applicable
- Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed ConditionsCompletedNCT01712126Not applicable
- Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted ConditionsCompletedNCT01712113Not applicable
- Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed ConditionsCompletedNCT01712100Not applicable
- Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine MonotherapyCompletedNCT01625494Phase 3
- Preeclampsia: A Marker for Future Cardiovascular Risk in WomenSuspendedNCT01519297Not applicable
- Irbesartan Versus Amlodipine: The OBI StudyWithdrawnNCT00987662Phase 4
- Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg MonotherapyCompletedNCT00957554Phase 3
- Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg MonotherapyCompletedNCT00956644Phase 3
- Irbesartan and Amlodipine Combination in Controlling Blood PressureCompletedNCT00950066Phase 2
- Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal AllograftsCompletedNCT00933231Phase 3
- Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese PopulationCompletedNCT00847834Phase 4
- Saving Residual Renal Function Among Haemodialysis Patients Receiving IrbesartanCompletedNCT00791830Phase 3
- Role of AT1-receptor Blockers in Insulin-induced Vasodilation.Status unknownNCT00742066Not applicable
- Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive PatientsCompletedNCT00670566Phase 4
- Irbesartan and Adhesion Molecules in AFStatus unknownNCT00613496Phase 4
- Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical PracticeCompletedNCT00564187Phase 4
- The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild HypertensionCompletedNCT00562809Phase 4
- Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With MicroalbuminuriaCompletedNCT00561964Phase 3
- Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing AtenololCompletedNCT00549133Phase 4
- Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With HypertensionCompletedNCT00529750Phase 4
- Left Atrial Remodelling in Hypertension: Effects of Ramipril or IrbesartanStatus unknownNCT00517322Phase 4
- Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate HypertensionCompletedNCT00500604Phase 4
- Irbesartan/Hydrochlorothiazide National Taiwan University Hospital ListingCompletedNCT00443612Phase 4
- I PREVENT - Irbesartan In Hypertensive Diabetic PatientsCompletedNCT00362258Phase 4
- I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular HypertrophyCompletedNCT00362037Phase 4
- Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)CompletedNCT00352560Phase 3
- Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial FunctionsCompletedNCT00350038Phase 4
- Effect of Irbesartan on Insulin Sensitivity in Chronic Heart FailureCompletedNCT00347087Phase 4
- I SAVE - Irbesartan in Mild to Moderate Hypertensive PatientsCompletedNCT00335673Phase 4
- Irbesartan in Chinese Hypertensive Diabetics With MicroalbuminuriaCompletedNCT00334581Phase 4
- Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent MicroalbuminuriaCompletedNCT00320879Phase 4
- ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment ElevationCompletedNCT00296218Phase 3
- APROVE : Irbesartan in HypertensionCompletedNCT00283036Phase 4
- Irbesartan in HypertensionCompletedNCT00265967Phase 4
- Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis CCompletedNCT00265642Phase 3
- Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate HypertensionCompletedNCT00263003Phase 3
- Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent PacemakersStatus unknownNCT00225667Phase 3
- PHARES Study: Management of Resistant HypertensionCompletedNCT00224549Phase 4
- The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy SubjectsCompletedNCT00185055Phase 4
- Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.CompletedNCT00180024Not applicable
- VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term HemodialysisCompletedNCT00171080Phase 3
- Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.CompletedNCT00154024Not applicable
- Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With HypercholesterolemiaWithdrawnNCT00152698Phase 3
- Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)CompletedNCT00125645Phase 4
- Irbesartan in the Treatment of Hypertensive Patients With Metabolic SyndromeCompletedNCT00110422Phase 4
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionCompletedNCT00095550Phase 3
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionCompletedNCT00095394Phase 3
- Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaCompletedNCT00095290Phase 4